Finding a cure for inflammatory bowel disease (IBD) would mean reducing treatment waste, according to Ashwin N.

The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.

The survey was conducted from March 10 through April 9, when the Department of Government Efficiency was in news ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

The latest report by Urban Institute warns that proposed Medicaid funding cuts could cost states like California, New York, ...

Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

For payers, claims for rare disease treatments used to be uncommon. Not now with an increasing number of new, high-priced ...

TIX100 is a small molecule inhibitor of TXNIP, a protein involved in cellular stress response and metabolism. This protein ...

Plans expect cell and gene therapies to pose a moderate or major financial challenge in the next two to three years, ...

Nirvana, a healthcare technology startup, uses artificial intelligence to better predict insurance coverage. When Kelvin Chan ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...